Scientific evidence of AKK probiotics published in the authoritative journal Cell - Part One

Acetobacterium muciniphila (AKK bacteria, abbreviated as AKK) is an important intestinal probiotic. It has published several highly influential articles in the series of Cell (including Cell, Cell Reports, Cell Host & Microbe, etc.). These studies mainly focus on the mechanisms of the relationship between AKK bacteria and host metabolism, immune response, and diseases. Here are the main articles of AKK bacteria in the Cell series and their core scientific conclusions (as of April 6, 2025, based on existing literature and research trends)

1. Cell (2022) – “Gut microbiome of multiple sclerosis patients and paired household healthy controls reveal associations with disease Zawrisk and course”

·Date: September 15th, 202

· Main Conclusion:

In the study of the gut microbiota of patients with multiple sclerosis (MS) and their healthy cohabiting controls, it was found that the abundance of AKK bacteria in the gut of MS patients was significantly increased.

The AKK bacteria may be related to the pathogenesis of MS by regulating the immune response (such as promoting the differentiation of Th1 cells), but the specific role of these bacteria (pro-inflammatory or protective) still requires further investigation.

Studies have shown that the abundance of AKK bacteria may serve as a potential biomarker for the risk and progression of MS (multiple sclerosis).

2. Cell Host & Microbe (2019) – “Oral administration of miR-30d from feces of MS patients suppresses MS-like symptoms in mice by expanding Akkermansia muciniphila”

·Date: November 6th, 2019

· Main Conclusion:

The miR-30d extracted from the feces of MS patients can significantly increase the abundance of AKK bacteria in the intestines of mice through oral administration, thereby alleviating the symptoms similar to those of MS.

The amplification of AKK bacteria is associated with enhanced intestinal barrier function and a reduction in pro-inflammatory factors (such as IL-17), suggesting that it may have a potential protective effect in neuroimmune diseases.

The study revealed the mechanism by which fecal miRNAs regulate the AKK bacteria to mediate the gut-brain axis.

3. Cell Reports (2017) – “NLRP6 protects Il10−/− mice from colitis by limiting colonization of Akkermansia muciniphila”

·Date: April 25th, 2017

· Main Conclusion:

In IL-10 knockout mice (susceptible to colitis), NLRP6 (an inflammation-related protein) protects the mice from colitis by limiting the excessive colonization of AKK bacteria.

Under conditions lacking IL-10, the AKK bacteria may exacerbate inflammation due to the thinning of the mucus layer, indicating that their effect is dual: beneficial under normal circumstances, but potentially harmful in specific immune deficiency states.

The study highlights the complex interplay between the host immune system and the colonization of AKK bacteria.

4. Cell Reports (2023) – “Akkermansia muciniphila-derived extracellular vesicles influence gut permeability and metabolism”

·Date: May 30, 2023

· Main Conclusion:

The extracellular vesicles (Akk-EVs) secreted by the AKK bacteria significantly improve intestinal permeability by enhancing the expression of intestinal tight junction proteins (such as ZO-1).

Akk-EVs reduce metabolic endotoxemia in mice on a high-fat diet, improve insulin sensitivity and lipid metabolism, suggesting that they exert their effects through the gut-liver axis.

Studies have shown that Akk-EVs are an important part of the functions of AKK bacteria and have the potential to be developed into therapeutic agents for metabolic diseases.

Summary of Main Scientific Findings

1. Metabolism and Intestinal Barrier: AKK bacteria and their derivatives (such as extracellular vesicles) enhance intestinal barrier function and reduce metabolic endotoxemia, thereby improving metabolic health, especially in obesity and insulin resistance models.

2. Duality of Immune Regulation: The AKK bacteria typically have anti-inflammatory effects in a healthy state (such as through short-chain fatty acids or outer membrane proteins), but in certain diseases (such as IL-10 deficiency or MS), they may exhibit pro-inflammatory properties due to environmental changes.

3. Neuroimmunology and the Gut-Brain Axis: The AKK bacteria may influence the progression of neurodegenerative diseases by regulating the intestinal microbiota and its metabolites (such as through miRNA-mediated mechanisms), demonstrating their potential role in the gut-brain axis.

4. Treatment potential: The AKK bacteria and its components (such as extracellular vesicles) are considered as potential candidates for the next generation of probiotics or therapeutic agents, which can be used for metabolic disorders, inflammatory bowel diseases, and immune-related diseases.

Notes and Outlook

The research on AKK bacteria in the Cell series mainly focuses on exploring its mechanisms and transformation potential. Compared to the Nature or Science series, the articles in the Cell series place more emphasis on molecular details and causal relationships in disease models. In the future, there may be more studies focusing on the specific roles of AKK bacteria in the human body and their interactions with other microorganisms, providing more solid evidence for its clinical applications.